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Abstract
MicroRNAs (miRNAs) are important regulators of gene expression that control physiological and pathological processes.
A global reduction in miRNA abundance and function is a general trait of human cancers, playing a causal role in the
transformed phenotype. Here, we sought to newly identify genes involved in the regulation of miRNA function by
performing a genetic screen using reporter constructs that measure miRNA function and retrovirus-based random gene
disruption. Of the six genes identified, RACK1, which encodes ‘‘receptor for activated protein kinase C’’ (RACK1), was
confirmed to be necessary for full miRNA function. RACK1 binds to KH-type splicing regulatory protein (KSRP), a member of
the Dicer complex, and is required for the recruitment of mature miRNAs to the RNA-induced silencing complex (RISC). In
addition, RACK1 expression was frequently found to be reduced in hepatocellular carcinoma. These findings suggest the
involvement of RACK1 in miRNA function and indicate that reduced miRNA function, due to decreased expression of RACK1,
may have pathologically relevant roles in liver cancers.
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Introduction
MicroRNAs (miRNAs) are short (20-23-nt), endogenous, single-
stranded RNA molecules, that regulate gene expression and control
physiological and pathological processes, such as development and
cancer. Mature miRNAs and Argonaute (Ago) proteins form the
RNA-induced silencing complex (RISC), a ribonucleoprotein com-
plex that mediates post-transcriptional gene silencing [1] and then,
complementary base-pairing of miRNAs guides the RISC to target
messenger mRNAs, which are subsequently destabilized and
sequestered from the translational machinery by Ago proteins [2–5].
Although insights into the regulatory function of miRNAs are
beginning to emerge, their mechanisms of action and the genes
involved in miRNA pathway have not yet been fully determined [6,7].
A large body of evidences suggests that the multigene regulatory
capacity of miRNAs is dysregulated and exploited in cancer.
Although several miRNAs are upregulated in specific tumors [8], a
global reduction of miRNA abundance appears a general trait of
human cancers, playing a causal role in the transformed
phenotype [9,10]. In fact, the enzymes and cofactors involved in
miRNA processing pathways may be targets of genetic disruption,
further enhancing cellular transformation [9]. Moreover, the
disruption of Dicer in mice promotes hepatocarcinogenesis [11]
and the truncating mutations in TARBP2, which causes a defect in
the processing of miRNAs, were identified in sporadic and
hereditary colon carcinomas [12].
Retroviral insertion-mediated random gene disruption can be
used to generate null alleles, resulting in diminished endogenous
gene expression [13]. The use of such retroviral integration
methods, combined with appropriate reporter constructs, has
provided an efficient, comprehensive gene screening method
[14,15]. In this study, we sought to identify new genes involved in
miRNA function and determine its role in live cancers. To this
end, we established reporter cell lines in which cellular miRNA
function could be assessed by expression of a drug resistance gene.
Using these cell lines and a random gene disruption method, we
identified genes that have not previously been implicated in the
regulation of miRNA function. We subsequently determined the
role of one of these genes, RACK1, which encodes ‘‘receptor for
activated protein kinase C’’ (RACK1), in miRNA function, as well
as its expression in liver cancers. Collectively, our data suggest the
potential involvement of RACK1 in pathological processes.
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Identification of the genes required in the miRNA
pathway by random gene disruption
To identify genes involved in miRNA pathways especially in liver
cells, we constructed a reporter carrying a hygromycin resistance
gene with two miR122-responsive elements in its 39-UTR (Fig. 1A).
We chose miR122 because it is the most abundant and tissue-
specific miRNA in the liver [16]. Binding of miR122 reduces the
expression of this hygromycin resistance gene in this construct.
However, if miR122 function is impaired by the disruption of genes
that are important for miRNA signaling, hygromycin resistance
gene expression increases. Cells carrying such disrupted genes will
therefore survive hygromycin treatment. Additionally, to enhance
the effects of miR122, we co-transfected a miR122 precursor-
expressing plasmid (Fig.1A)with thereporterconstructandselected
monoclonal cells containing both constructs to minimize the effects
of their random integration. After infection with retroviruses
carrying a blasticidin resistance gene to produce random gene
disruption in the selected reporter cells, cells surviving hygromycin
treatment were harvested. The disrupted genes in the surviving cells
were identified by 39 RACE. We infected ,10
6 Huh7-pBS-Hygro-
miR122 cells established from Huh7 cells and obtained ,10
4 clones
with random gene disruptions (confirmed by resistance to
blasticidin) (Fig. 1B). After hygromycin selection, ten clones in
which miRNA function was apparently impaired were obtained. In
these ten clones, six disrupted genes were successfully identified
(Table 1). One of them, RACK1 (also known as GNB2L1),
appeared in duplicate and was found to be disrupted in two clones.
Requirement of RACK1 for microRNA function
Of the genes identified, RACK1 was found to be disrupted in
two independent clones (Table 1). RACK1 was previously
identified as the binding partner of eIF6, a ribosome inhibitory
protein known to prevent proper assembly of the 80S ribosome,
and contributes to miRNA silencing by associating with RISC
[17–19]. However, the requirement for eIF6 in miRNA function is
controversial because other models, in which miRNA silencing is
mediated by Ago2 (eIF2C2) and an interaction with eIF4E [20], or
by GW182 [21], have more recently been described.
To confirm the requirement for RACK1 in miRNA function,
we measured miRNA activity using a reporter assay involving
transient expression of an siRACK1 construct and an miRNA
precursor-overexpression plasmid. Transient knockdown of
RACK1 reduced the function of three miRNAs: miR122,
miR140, and miR185 (Fig. 2A). To examine these effects using
a natural 39-UTR containing miR122 binding sites, we used a
CatA-Luc reporter that carried the 39-UTR of the CAT1 (cationic
amino acid transporter 1) gene and a luciferase gene [22]. The
CAT1 39-UTR contains three predicted miR122 binding sites
[22]. The requirement for RACK1 in miRNA function was
confirmed using this reporter construct (Fig. 2B).
Next, we established stable RACK1-knockdown Huh7 cells
(Fig. 2C) and compared the effects of miRNAs in control and
RACK1-knockdown cells. Consistent with the results of the
transient transfection assays, RACK1-knockdown cells showed
weaker miRNA mediated-inhibition of target gene expression in a
reporter system involving miR185 precursor-expressing plasmids
and its reporter constructs (Fig. 2D). To measure changes in
endogenous miRNA function in RACK1-knockdown cells, control
and RACK1-knockdown cells were transfected with reporter
constructs specific for several miRNAs and luciferase activity was
then measured. We confirmed the inhibition of endogenous
miRNA function in RACK1-knockdown cells (Fig. 2E). These
results suggest that RACK1 is indeed required for miRNA
function.
RACK1 may function after miRNA maturation but before
the expression-inhibitory machinery
To identify the point at which RACK1 enhances miRNA
function, mature miRNA levels were first measured in stable
RACK1-knockdown cells. Levels of endogenous mature miR122,
miR22, miR140-5p, -3p, and miR185, which are expressed at
relatively high levels in liver cells [16], were comparable in control
and RACK1-knockdown cells (Fig. 3A and Figure S1). This
suggests that RACK1 may not be involved in miRNA maturation.
We next showed that overexpression of artificial synthetic miRNA
oligonucleotides replicated normal miRNA-mediated inhibition
of gene expression in RACK1-knockdown cells (Fig. 3B). These
results suggest that, in vivo, RACK1 may function after miRNA
maturation, but before the expression-inhibiting machinery in the
natural miRNA pathway, although the finding that the synthetic
mature miRNAs were functional even in Ago2-knockdown cells
(Figure S2A, B) indicates that their function might be Ago2-
independent. Additionally, the expression of Drosha, DGCR8,
Dicer, TRBP, Ago1, Ago2, Ago3, Ago4, and eIF4E, all of which
are known to be involved in the miRNA pathway, were almost
similar in control and RACK1-knockdown cells (Fig. 3C).
Furthermore, the localization and number of the p-bodies, which
may be involved in miRNA-mediated silencing [23,24], were not
markedly affected by RACK1-knockdown (as determined by
staining for the intracellular marker GW182) [23] (Fig. 3D). These
results suggest that RACK1 functions after miRNA maturation,
but before mature miRNAs exert their expression-inhibitory
effects.
RACK1 interacts with KSRP and is required for the full
recruitment of mature miRNAs to the RISC
To determine whether RACK1 interacts with miRNA pathway
related-molecules, transiently-transfected myc-tagged RACK1 was
first immunoprecipitated. While myc-tagged RACK1 was efficiently
precipitated (Fig. 4A), RISC constituent proteins such as Dicer,
DDX20 (Gemin3) and Gemin4 [25] were found not to interact with
R A C K 1( F i g .4 A ) .G W 1 8 2d i dn o ti n t e r a c tw i t hR A C K 1( F i g .4 A ) .
eIF6, which was previously reported to interact with RACK1 [18]
and which may be involved in miRNA silencing [19], did not show
an interaction with RACK1 in the present study (Fig. 4A). However,
Ago2 weakly interacted with RACK1 (Fig. 4A), as reported recently
[26]. Moreover, KH-type splicing regulatory protein (KSRP; also
known as KHSRP), a key mediator of mRNA degradation [27,28]
and a component of the Dicer complex that promotes the maturation
of a subset of miRNAs [29], interacted with RACK1, especially when
Dicer was overexpressed (Fig. 4A and Figure S3). This interaction
was also confirmed by immunoprecipitation of endogenous RACK1
(Fig. 4B). The interactions of R A C K 1w i t hA g o 2a n dK S R Pw e r e
insensitive to RNase A treatment (Figure S4), suggesting that they
were not mediated by RNAs. Next, because it seemed that RACK1
functioned after miRNA maturation and before mature miRNA
recruitment into the RISC, we measured levels of miRNAs in
complexes immunoprecipitated using an anti-Ago2 antibody. Levels
of mature miRNAs examined in the Ago2-containing complexes
were lower in RACK1-knockdown cells than in control cells (Fig. 4C
and Figure S5). To determine the possible causes of impaired mature
miRNAloading into Ago2-related complexesin RACK1-knockdown
cells, we determined the intracellular localization of KSRP and Ago2
in RACK-1 knockdown cells (Fig. 4D). While KSRP is distributed
both in the nucleus and cytoplasm and Ago2 localizes mainly in
RACK1 Is Required for Full MicroRNA Function
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24359cytoplasm in control cells, KSRP localizes more in the nucleus in
RACK1-knockdown cells (Fig. 4D). The changes in the subcellular
localization of KSRP in RACK1-knockdown cells were also
confirmed by Western blotting using cell lysates prepared after
subcellular fractionation (Fig. 4E). The function of synthetic mature
miRNAs was not affected by KSRP knockdown (Figure S6A, B),
suggesting that KSRP itself is not required for RISC activity. Thus,
these localization changes with RACK-1 may be related to the
impaired mature miRNA loading into Ago2 complexes from the
KSRP-associated complexes, although, because the binding of KSRP
to Ago2 could not be detected in our coimmunoprecipitation study
(Figure S7), the precise mechanisms remain to be elucidated.
Nonetheless, these results suggest that RACK1 interacts with KSRP
a n dt h a tt h er e c r u i t m e n to fm a t u r em i R N A si n t ot h eR I S Ci s
impaired in RACK1-knockdown cells.
RACK1 expression is frequently decreased in liver cancers
Recent results linking reduced global expression of miRNAs and
reduced miRNA function with tumorigenesis [12,30] encouraged
us to examine RACK1 expression in cancers. To this end, we
Figure 1. Constructs used in the study. A, Reporter and miR122 precursor-expressing constructs. A construct containing an SV40 promoter-
driven hygromycin resistance gene with two tandem miR122-responsive elements (miR122 RE) in its 39-UTR was used to assess miRNA function. To
express miR122, a construct carrying a CMV promoter-driven miR122 precursor was used in conjunction with puromycin selection. B, pDisrupt vector
structure and gene products resulting from viral integration. Splicing occurs between the SD (splicing donor) and SA (splicing acceptor) sites (i.e.,
between the 39-end of the endogenous gene exon and the retroviral SA site, as well as between the retroviral SD at the 39-end of the blasticidin gene
and the endogenous SA site at the 59-end of the downstream gene exon). pA, polyadenylation signal.
doi:10.1371/journal.pone.0024359.g001
Table 1. List of genes identified in this screening.
Gene ID Gene symbol Gene title Known function Also known as
100288263 LOC100288263 hypothetical protein Unknown
10399 GNB2L1 guanine nucleotide binding protein (G Translation RACK1, PIG21
protein), beta polypeptide 2-like 1
10055 SAE1 SUMO1 activating enzyme subunit 1 Sumoylation AOS1, SUA1, UBLE1A
10399 GNB2L1 guanine nucleotide binding protein (G Translation RACK1, PIG21
protein), beta polypeptide 2-like 1
6228 RPS23 ribosomal protein S23 Ribosome 40S FLJ35016
6135 RPL11 ribosomal protein L11 Ribosome 60S DBA7, GIG34
5358 PLS3 plastin 3 Actin binding T-plastin
doi:10.1371/journal.pone.0024359.t001
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tissues by immunohistochemistry. While RACK1 expression was
essentially normal in most cancers, it was frequently reduced in
hepatocellular carcinoma (HCC) (Fig. 5A, B, C), consistent with a
previous report [31]. KSRP expression levels were relatively
higher in liver tissues than in other organs, but no remarkable
expression differences between HCC and adjacent tissues were
observed (Figure S8A, B). These results suggest that decreased
Figure 3. RACK1 functions after miRNA maturation and before the silencing machinery. A, miRNA maturation was not impaired in
RACK1-knockdown cells. Total RNA was isolated from control and RACK1-knockdown cells. Levels of mature miR122 were measured and normalized
to the level of U6 snRNA. Relative ratios were calculated by adjusting the value for each miRNA in control cells to 1. Data represent the mean 6 SD of
six independent experiments. B, Artificial synthetic miRNA oligonucleotides function appropriately in RACK1-knockdown cells. Control Huh7 cells and
RACK1-knockdown cells were transfected with miR122 reporter plasmids with or without synthetic corresponding miR122 oligonucleotides and non-
corresponding miR185 oligonucleotides (to verify specificity). Values were normalized to those obtained from the cells transfected with control
synthetic oligonucleotides, which were set to 1. Data represent the mean 6 SD of three independent experiments. *, p,0.05. Similar results were
obtained using PLC/PRF/5 cells. C, Expression of proteins involved in the miRNA pathway was normal in RACK1-knockdown cells. 293T cell lysates
were used as a positive control. D, Localization and expression of P-bodies were normal in RACK1-knockdown cells. Control and RACK1-knockdown
cells were immunostained for the p-body marker GW182. Scale bar, 50 mm.
doi:10.1371/journal.pone.0024359.g003
Figure 2. RACK1 is required for miRNA function. A, Overexpression of miR122, miR140, and miR185 precursors suppressed activity of the
corresponding reporters. RACK1 knockdown partially blocked these effects. miRNA reporter plasmids were transfected, with or without the
corresponding miRNA precursor- and two types of siRACK1-expressing plasmids (siRACK1 (1) and (2)), into Huh7 cells. Values were normalized to
those obtained from cells transfected with a miRNA precursor-non-expressing control vector, which were set to 1. Data represent the mean 6 SD of
three independent experiments. siGFP was used as a control, and it had no effect. Similar results were obtained using PLC/PRF/5 cells. B, CatA-Luc
plasmids, which contain endogenous miR122 target sites derived from the CAT1 gene in its 39-UTR, were transfected, with or without miR122
precursor- and siRACK1-expressing plasmids, into Huh7 cells. Data were generated and are presented as described in (A). Similar results were
obtained using PLC/PRF/5 cells. C, Confirmation of the efficient knockdown of RACK1 expression in stable RACK1-knockdown Huh7 cells. 293T cell
lysates were used as a positive control. D, miRNA function is impaired in stable RACK1-knockdown cells. miRNA185 reporter plasmids were
transfected, with or without miR185 precursor-expressing plasmids, into control and RACK1-knockdown cells. Data were generated and are
presented as described in (A). E, Endogenous miRNA function is impaired in RACK1-knockdown cells. miRNA185 reporter plasmids and CatA-Luc
plasmids were transfected without miRNA precursor-expressing plasmids into control and RACK1-knockdown cells to assess endogenous miRNA
function. Values were normalized to those obtained from control cells, which were set to 1. Data represent the mean 6 SD of three independent
experiments. *, p,0.05.
doi:10.1371/journal.pone.0024359.g002
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transfected with a control vector or a myc-tagged RACK1-expressing plasmid with or without a flag-tagged Dicer-expressing plasmid. Myc-tagged
RACK1 was immunoprecipitated using anti-myc agarose. Normal mouse IgG was used as a control for immunoprecipitation. Co-precipitated proteins
were blotted using antibodies against the indicated proteins. Five percent of the total cell lysates was loaded as ‘‘input.’’ Representative results
from two independent experiments are shown. Similar results were obtained using 293T cells. B, Endogenous RACK1 in Huh7 cells was
immunoprecipitated using anti-RACK1 antibody and Protein A/G Sepharose. Normal mouse IgG was used as a control for immunoprecipitation.
RACK1 Is Required for Full MicroRNA Function
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tion may play an important role in HCC.
Discussion
Here, we have shown that RACK1 is required for miRNA
function through comprehensive gene screening using a random
gene disruption method. Our results show that RACK1 interacts
with KSRP and plays an important role in recruiting mature
miRNAs to the RISC. Additionally, the expression of RACK1 is
frequently decreased in HCC and may play a role in its
pathogenesis.
RACK1 was initially identified as a major component of active
ribosomes [18]. It binds directly to eIF6, which keeps the 40S and
60S ribosomal subunits apart, preventing the formation of a
translationally competent complex. RACK1 bridges PKC and
eIF6. Subsequent phosphorylation of eIF6 by PKC causes eIF6 to
be released, an event that triggers 60S subunit activation. More
recently, eIF6 was reported to be a component of a large TRBP-
containing complex involved in miRNA-mediated post-transcrip-
tional silencing [19]. However, the importance of eIF6 in miRNA-
mediated silencing remains controversial [21]. In this study, we
report that, although RACK1 is involved in miRNA-mediated
silencing, it did not influence of translational machinery complexes
containing eIF6, but instead appears to recruit mature miRNAs to
the RISC.
The importance of RACK1 in regulating miRNA function was
independently reported during the preparation of this manuscript
[26]. Similar to our cases, they reported that RACK1 is required
for miRNA function; however, the mechanism they reported
differed from ours. They found that RACK1 contributes to the
recruitment of RISC to the site of translation through binding with
Ago2. While we could not detect the effects of RACK1 on
miRNA-mediated translational repression as described above, our
results were based on the use of synthesized mature miRNAs,
which appear functionally Ago2-independent. Due to the fact that
we also detected binding between RACK1 and Ago2, their
proposed mechanism remains a possibility [26]. In addition, the
importance of these diverse mechanisms might be dependent on
different types of miRNAs. For example, the maturation of
miRNAs used in our study, i.e., miR122, miR140, and miR185, is
KSRP-independent [29]. Taking these points into consideration,
in the future it may be necessary to determine if RACK1 is
involved in different types of miRNA function under the same
mechanisms, using various kinds of miRNAs.
We found that RACK1 interacts with KSRP particularly when
Dicer is overexpressed. KSRP is a key mediator of AU-rich
element-containing mRNA degradation [27,28] that has also been
reported to bind to and promote the maturation of a subset of
miRNA precursors [29]. In our study, however, maturation of
miRNAs examined was preserved and the transfected synthetic
miRNAs functioned appropriately in RACK1-knockdown cells.
Moreover, levels of miRNAs in Ago2-containing complexes were
decreased in RACK1-knockdown cells. Based on these observa-
tions, we speculate that RACK1 is only involved in the recruitment
of mature miRNAs to RISCs from miRNA maturation to the point
at which they exert their effects in vivo. Although the precise
mechanisms by which RACK1 contributes to the recruitment of
miRNAs to RISCs and the biological significance of its binding to
KSRP remains to be determined, these results suggest that RACK1
may regulate miRNA function as a component of a KSRP complex
and during the maturation of miRNAs and their recruitment to
RISCs.
Translationally repressed mRNA accumulates in discrete cyto-
plasmic foci known as p-bodies [24] or in another class of
cytoplasmic aggregates, stress granules [32]. Although RACK1
has been reported to mediate stress granule formation [33], no
change in the localization of p-bodies or expression of the p-
body marker GW182 was detected in RACK1-knockdown cells
in the present study. Additionally, no interaction between p-
bodies and RACK1 was observed. We thus conclude that
RACK1 does not produce p-body-related effects in the miRNA
pathway.
Retroviral insertion-mediated random gene disruption screen-
ing in this study identified several genes involved in miRNA
function. Functional genomics approaches involving RNAi
libraries have recently been used to identify genes involved in
certain functional pathways [34–37]. However, RNAi libraries
may not be suitable for identifying genes involved in miRNA- or
siRNA-related pathways, because they affect the pathways being
examined. Thus, random gene disruption, as used here, may be
a useful alternative option for the functional screening of such
genes.
While identified genes here did not include well-known
components of the miRNA pathway such as Dicer and Ago2,
these genes may be critical for cell survival, which would make
their selection by survival screening impossible. Alternatively, it
may be that the screening required a greater number of cells.
Nonetheless, we newly identified six genes that may potentially be
involved in miRNA function. Of the genes identified, two, RPS23
and RPL11, are ribosome-related molecules, encoding 40S and
60S subunit proteins, respectively. In view of the fact that one of
RACK1’s roles is as a mediator of the synthesis of 80S ribosomes
(composed of 40S and 60S subunits) [18], these results may
suggest the importance of the ribosomal machinery in miRNA
function.
Consistent with recent evidence linking global microRNA
depletion with oncogenesis [12,30], RACK1 expression was found
to be reduced in HCC. Because RACK1 staining in non-
cancerous liver tissues was stronger than that in other tissues, the
involvement of RACK1 in physiological functions may be more
relevant in the liver. These results suggest that the miRNA
functional impairment plays an important role in oncogenesis in
the liver and/or the maintenance of oncogenicity in HCC, similar
to the deficiency of miRNA expression [11].
Coprecipitated proteins were blotted using antibodies against the indicated proteins. Five percent of the total cell lysate was loaded as ‘‘input.’’
Representative results from two independent experiments are shown. C, Levels of mature miR122 and miR185 in Ago2-containing complexes were
reduced in RACK1-knockdown cells. Mature miRNA levels were measured in RNA samples isolated from Ago2-containing complexes from control
Huh7 (NC) cells and RACK1-knockdown (siRACK1) cells. miRNA levels were calculated as relative ratios. Data represent the mean 6 SD of six
independent experiments. *, p,0.05. D, More KSRP localizes in the nucleus in RACK1-knockdown cells. Intracellular localization of KSRP (red) and
Ago2 (green) were examined in control and RACK1-knockdown cells. KSRP was distributed both in the nucleus and cytoplasm, but more KSRP
localized in RACK1-knockdown cells. Scale bar, 50 mm. E, Greater localization of KSRP to the nucleus in RACK1-knockdown (RACK1 KD) cells was
confirmed by Western blotting. Cytoplasmic (C) and nuclear (N) fractions were blotted with anti-KSRP antibody. The numbers below the panel
indicate relative KSRP protein levels. GAPDH (a cytoplasm marker) and Lamin B (a nucleus marker) were blotted to confirm the appropriate
fractionation.
doi:10.1371/journal.pone.0024359.g004
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Cell culture
Huh7 and PLC/PRF/5 cells were obtained from the Japanese
Collection of Research Bioresources (JCRB, Osaka, Japan). 293T
cells were obtained from the American Type Culture Collection
(ATCC, Rockville, MD). Cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS). Stable cell lines derived from Huh7 and
PLC/PRF/5 cells were established by retroviral or lentiviral
infection. Clones were selected through the addition of 6 mg/mL
puromycin, 400 mg/mL hygromycin, or 5 mg/mL blasticidin to
the culture medium, unless otherwise specified.
Random gene disruption
The use of a pDisrupt retroviral vector carrying a blasticidin
resistance gene for random gene disruption has been described
previously [13]. Retroviruses were produced by transfection of the
retroviral vector into virus-packaging Platinum A cells (Orbiden,
San Diego, CA). Then, 48 h after transfection, the supernatants
were harvested and viruses collected. To prepare reporter cell
Figure 5. RACK1 expression is reduced in HCC. A, Immunohistochemical analysis of RACK1 protein expression in HCC and non-cancerous
surrounding tissues. While strong staining was observed in the cytoplasm of hepatocytes in non-cancerous liver tissues (upper left (one panel)), HCC
cells were stained more weakly (upper right). Lower panels: magnified images of the highlighted regions in the corresponding upper panels. Three
representative cases are shown. Scale bar, 500 mm. B, Comparable expression of RACK1 in colon carcinoma tissues (right images) and non-cancerous
surrounding tissues (left). Two representative cases are shown. Scale bar, 500 mm. C, Comparison of RACK1 staining in cancers and healthy
surrounding tissues. Eight types of cancers were examined. Percentages of cases in which RACK1 expression was lower in cancerous tissues than in
healthy tissues were calculated. The number of cases of each type of cancer studied is indicated.
doi:10.1371/journal.pone.0024359.g005
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selected on hygromycin. To avoid random integration in
polyclonal cells, single clones were picked and expanded. The
selected clones were then infected with MIR122-puro lentiviruses,
which express a miR122 precursor and a puromycin resistance
gene, and selected on puromycin. Again, several individual clones
were isolated and expanded separately to avoid random
integration. Using selected Huh7-pBSII-Hygro-miR122 cells and
parental Huh7-pBSII-Hygro cells, titration of the hygromycin
concentration required for total cell killing was performed to
determine the clone showing the widest differences in hygromycin
concentration (i.e., the clone in which expression of the
hygromycin resistance gene was most effectively suppressed by
miR122). Next, this clone was infected with retroviruses at low
multiplicities of infection (,0.01) to achieve random gene
disruption and then treated with blasticidin. Blasticidin-resistant
cells carry viruses inserted in functional genes (otherwise, the
blasticidin resistant gene cannot be expressed). Then, hygromycin
was added to select hygromycin resistant cells, which potentially
have impaired miR122 function as a result of gene disruption
(which itself results in impaired suppression of hygromycin
resistance gene expression). Such clones were picked and 39-rapid
amplification of cDNA ends (RACE) analysis of the mRNAs fused
with the blasticidin gene used to identify the disrupted gene in
each clone.
39-RACE
We infected ,106 Huh7-pBS-Hygro-miR122 cells and ob-
tained ,104 blasticidin-resistant clones. After selection, ten
surviving clones were obtained. The endogenous gene sequence
fused with the blasticidin gene was amplified by 39-RACE. Total
RNA was isolated and reverse transcribed using an RT primer (5-
CCA GTG AGC AGA GTG ACG AGG ACT CGA GCT CAA
GC (T)17 -39). A nested PCR was performed using primers P0/Q0
(59-GGT GTC GAC AGG TGC TTC TC-39/59-CCA GTG
AGC AGA GTG ACG-39) and P1/Q1 (59-CTG GGA TCA AAG
CGA TAG TG-39/59-GAG GAC TCG AGC TCA AGC-39). P0
and P1 anneal to sequences in the blasticidin resistance gene and
Q0 and Q1 to the anchor sequences of the RT primer. The PCR
fragments were finally subcloned into a TA-cloning vector
(Invitrogen, Carlsbad, CA) and sequenced.
Plasmids
A pBSII-Hygro plasmid containing miR122REs in its 39-UTR
was generated from pGL4-Hygro, purchased from Promega
(Madison, WI). Synthetic oligonucleotides containing two tandem
miR122-responsive elements were annealed and inserted in the 39-
UTR of this plasmid’s hygromycin resistance gene (at the PmeI
site). The primer used was 59-AAA CAC AAA CAC CAT TGT CAC
ACT CCA AAT TAC AAA CAC CAT TGT CAC ACT CCA CTC
GAG-39 (miR122-responsive sequences are shown in italics). Next,
the gene cassette (containing an SV40 promoter, the hygromycin
resistance gene, the miR122 responsive elements and polyA
sequences) was excised using BamHI and SalI, and was inserted
into pBlueScript II at the same restriction sites. pMIR-122-puro
was constructed by replacing the eGFP gene of pMIRH122PA
(System Biosciences, Mountain View, CA) at the FseI site by a
puromycin resistance gene, which was PCR-amplified using
pCDH-EF1a-puro (System Biosciences) as a template. The
following primers were used: 59-GGC CGG CCG CAT GAC
GAG TAC AAG CCC AC-39 and 59-GGC CGG CCT CAG
GCA CCG GGC TTG CGG GT-39. pcDNA3-myc-RACK1 was
used to achieve RACK1 overexpression. Two constructs targeting
different RACK1 sequences, pSIH-H1-RACK1shRNA and
pSuper.retro-RACK1 shRNA (both provided by Prof. Takekawa
[33]), were used to achieve RACK1 knockdown. pSIH-H1-GFP
shRNA was constructed as a control, as described previously [38].
To determine the effect of miR-122 on natural gene targets, a
reporter plasmid (CatA-Luc) with natural 39-UTR sequences of
the CATT1 (cationic amino-acid transporter (CAT-1)) gene
containing three predicted miR-122 binding sites was used. This
plasmid was provided by Prof. W. Filipowicz [22]. Reporter
plasmids used to analyze miRNA function were constructed by
inserting annealed synthetic primers containing two tandem
sequences complementary to each miRNA into the 39-UTR of
the firefly luciferase gene at the FseI site, driven by the CMV
promoter (pGL3-basic; Promega). The following primers were
used: miR-122, 59-ACA AAC ACC ATT GTC ACA CTC CAA
CTT CAC CCA ACC ATT GTC ACA CTC CAC TCG AGC
CGG-39; miR-140-5p, 59-CTA CCA TAG GGT AAA ACC
ACT GAA TTC TAC CAT AGG GTA AAA CCA CTG CTC
GAG CCG G-39; miR-185, 59-TCA GGA ACT GCC TTT CTC
TCC AAA TTT CAG GAA CTG CCT TTC TCT CCA CTC
GAG CCG G-39. The flag-tagged Dicer-expressing plasmid has
been described previously [39]. MiR precursor overexpressing
plasmids were purchased from System Biosciences.
Transfection
Plasmid transfection was performed using FuGENE6 (Boehrin-
ger Mannheim, Mannheim, Germany) according to the manu-
facturer’s protocol [40]. Synthetic mature miRNA oligonucleo-
tides (miNatural, CosmoBio, Tokyo, Japan) were transfected using
TransMessenger Transfection Reagent (Qiagen, Hilden, Ger-
many).
Antibodies
The following antibodies were used in Western blotting analyses:
anti-Dicer (SAB4200087; Sigma, St. Louis, MO), anti-TRBP2
(SAB4200087; Sigma), anti-b-actin (A5316; Sigma), anti-Ago2
(#015-22031; Wako, Osaka, Japan), anti-Gemin3 (DDX20) (SC-
57007; Santa Cruz Biotechnology, Santa Cruz, CA), anti-Gemin4
(H00050628; Abnova, Taipei, Taiwan), anti-eIF4E (#9742; Cell
Signaling Technology, Danvers, MA), anti-eIF6 (D16E9; Cell
Signaling Technology), anti-KSRP (A302-021A; Bethyl, Montgomery,
TX), anti-GW182 (MBL Nagoya, Japan), anti-Drosha (#3364; Cell
Signaling Technology), anti-DGCR8 (SAB 4200088; Sigma), anti-
Ago1 (clone1F2; Wako, Osaka, Japan), anti-Ago3 (SAB2104518;
Sigma), anti-Ago4 (SAB2104338; Sigma), anti-Lamin B (SC-20682;
Santa Cruz Biotechnology), anti-GAPDH (clone 3C2; Abnova), and
anti-myc (Santa Cruz Biotechnology). An Atlas anti-RACK1 antibody
was used in immunohistochemical analyses (HPA021676; Sigma).
Western blotting
Cell extract protein concentrations were measured using a DC
Protein Assay Kit (Bio-Rad, Hercules, CA). Total protein (30 mg)
was resolved by sodium dodecyl sulfate- polyacrylamide gel
electrophoresis (SDS-PAGE) and then transferred to Hybond-P
polyvinylidene difluoride (PVDF) membranes (Amersham Phar-
macia Biotech, Little Chalfont, Buckinghamshire, UK). Mem-
branes were sequentially incubated with primary antibody and
horseradish peroxidase-conjugated secondary antibody. Bound
antibody was detected using ImmunoStar reagents (Wako) [41].
Cell fractionation
To separate cytoplasmic and nuclear protein fractions, a
ProteoExtract subcellular fractionation kit (Calbiochem-EMD Bio-
sciences, San Diego, CA) was used according to the manufacturer’s
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cytoplasmic fraction.
Immunocytochemistry
To determine the localization of p-bodies, cells growing on
two-well chamber slides were fixed with 4% paraformaldehyde
and permeabilized with 0.5% Triton-X100. Fixed cells were then
probed with an anti-GW182 antibody for 1 h after blocking with
5% normal goat serum for 30 min. They were then treated with
an Alexa Fluor 555-conjugated goat anti-rabbit secondary
antibody (Invitrogen) for 30 min. Slides were mounted using
VectaShield with DAPI (Vector Labs, Burlingame, CA). Num-
bers of p-bodies in the cells were determined in three
independent views, and the average number or p-bodies per cell
calculated. Similar procedures were applied to determine KSRP
and Ago2 intracellular localization, except that anti-KSRP and
anti-Ago2 were used as first antibodies, and Alexa Fluor 555-
conjugated goat anti-rabbit antibody and Alexa Fuor 488-
conjugated anti-mouse antibody were used as secondary anti-
bodies.
Immunohistochemistry
Tissue arrays containing multiple organ carcinoma tissues and
matched adjacent non-cancerous tissues (1.5 cm apart; #MC501
and #MC962) were purchased from US Biomax (Rockville, MD).
Slides were incubated at 65uC for 1 h and deparaffinized.
Endogenous peroxidase activity was blocked through incubation
in 3% hydrogen peroxide buffer for 30 min. Antigen retrieval was
achieved by incubating the slides at 89uC in 10 mM sodium citrate
buffer (pH 6.0) for 30 min. To minimize non-specific background
staining, slides were blocked in 5% normal goat serum (Dako,
Glostrup, Denmark) for 10 min at room temperature. A primary
anti-RACK1 antibody or anti-KSRP antibody, diluted 1:50 in
Antibody Diluent (Dako), was applied for 1 h at room
temperature. Slides were then incubated with an anti-mouse
horseradish peroxidase-conjugated secondary antibody (Nichirei
Bioscience, Tokyo, Japan) for 1 h. Bound antibody was visualized
by incubation in 3,39-diaminobenzidine (Nichirei Bioscience;
diluted in buffered substrate) for 5 min. The slides were finally
counterstained with hematoxylin, dehydrated with ethanol, and
mounted using Clarion mounting medium (Biomeda, Foster City,
CA).
Luciferase assay
Luciferase activity were measured using a Dual Luciferase
Reporter Assay System (Promega) in conjunction with a Lumat
LB9507 luminometer (EG&G Berthold, Bad Wildbad, Germany).
pRL-TK, a control plasmid carrying the Renilla reniformis (sea
pansy) luciferase gene, driven by the herpes simplex virus thymidine
kinase promoter (Toyo Ink, Tokyo, Japan), was used as an internal
control. Relative luciferase signals were calculated by dividing firefly
luciferase activity by that of the internal control (sea pansy
luciferase) (unless otherwise specified). All experiments were
performed at least twice (each time in triplicate).
Lentiviruses and transduction
293T cells were transfected with pPACKH1 Packaging Plasmid
Mix (System Biosciences) and pCDH (as a negative control),
pSIH-H1-RACK1shRNA, or pMIR122-puro. After 2 days,
supernatants were collected and the viruses concentrated using
PEG-it Virus Precipitation Solution (System Biosciences) accord-
ing to the manufacturer’s protocol. Lentiviral particles expressing
shRNAs specific for Ago2 (sc-44409) and KSRP (sc-44831) were
purchased from Santa Cruz Biotechnology. Polybrene (Millipore,
Billerica, MA) was used in lentiviral particle infection.
miRNA isolation, quantitation, and RIP assay
A Mir-X miRNA qRT-PCR SYBR Kit (Clontech, Mountain
View, CA) was used in accordance with the manufacturer’s
protocol to measure levels of different miRNAs in cells. Total
RNA was isolated from cells and tissues using the TRIzol reagent
(Invitrogen). Levels of U6 snRNA were used in the normalization
of cellular miRNA levels. Relative expression levels were
calculated by the DDCT method: DDCT = DCTmiRNA –
DCTU6. To purify miRNAs from Ago2-containing RISC-
associated miRNP complexes, miRNA fractions were isolated
using the Human Ago2 MicroRNA Isolation Kit (Wako), using
antibodies raised against Ago2. The following primers were used
in quantitative PCR analyses: miR122, 59-TGG AGT GTG ACA
ATG GTG TTT G-39; and miR-185, 59-TGG AGA GAA AGG
CAG TTC CTG A-39.
Immunoprecipitation
Huh7 cells were transfected with pcDNA3 (negative control) or
myc-tagged RACK1-expressing plasmid with or without Dicer-
expressing plasmid. When required, cell lysates were incubated at
room temperature with RNase A (10 mg/mL; Promega) for
30 min. Cell extracts were prepared using immunoprecipitation
buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP-40,
1 mM EDTA, 0.25% gelatin, 0.02% sodium azide, 100 mg/mL
phenylmethylsulfonyl fluoride, 1 mg/mL aprotinin). Myc-tagged
RACK1 was precipitated through incubation with anti-myc
agarose (#SC-40; Santa Cruz Biotechnology) for 8 h. Anti-KSRP
antibodies and Protein A/G Sepharose (#SC-2003; Santa Cruz
Biotechnology) were used for endogenous KSRP precipitation. To
immunoprecipitate endogenous RACK1 protein, anti-RACK1
antibodies and Protein A/G Sepharose were used. After being
washed four times, the precipitated proteins were analyzed by
Western blotting using the indicated antibodies. Five percent of
each cell lysate was used as ‘‘input.’’
Statistical analysis
Statistically significant differences between groups were identi-
fied using Student’s t-test (when variances were equal) or Welch’s
t-test (when variances were not equal).
Supporting Information
Figure S1 miRNA maturation was not impaired in
RACK1-knockdown cells. Total RNA was isolated from
control and RACK1-knockdown cells. Levels of mature miR22,
miR140-5p, miR140-3p, and miR185, all of which are relatively
abundant miRNAs in liver cells, were measured and normalized to
the level of U6 snRNA. Relative ratios were calculated by
adjusting the value for each miRNA in control cells to 1. Data
represent the mean 6 SD of six independent experiments.
(TIF)
Figure S2 Synthetic mature miRNAs were functional in
Ago2-kcnockdown cells. A, Ago2-knockdown (Ago2 KD)
Huh7 cells were established by shRNA-expressing lentiviral
infection. B, Artificial synthetic miRNA oligonucleotides function
normally in Ago2-knockdown Huh7 cells. Control and Ago2-
knockdown (Ago2 KD) cells were transfected with miR122 or
miR185 reporter plasmids with corresponding synthetic mature
miRNA oligonucleotides. Values were normalized to those
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otides, which were set to 1. Data represent the mean 6 SD of
three independent experiments. *, p,0.05.
(TIF)
Figure S3 RACK1 binds to KSRP. Huh7 cells were
transiently transfected with a control vector or a myc-tagged
RACK1-expressing plasmid, with or without a Flag-tagged Dicer-
expressing plasmid. Endogenous KSRP was immunoprecipitated
using anti-KSRP with Protein A/G Sepharose. Normal mouse IgG
was used as a control for immunoprecipitation. Co-precipitated
proteins were blotted using antibodies against myc tag. Five percent
of the total cell lysates was loaded as ‘‘input.’’ Representative results
from two independent experiments are shown.
(TIF)
Figure S4 Coimmunoprecipitation of endogenous KSRP
and Ago2 with myc-RACK1 is insensitive to RNase A
treatment.Huh7 cells were transiently transfected with a control
vector or a myc-tagged RACK1-expressing plasmid. Myc-tagged
RACK1 was immunoprecipitated using anti-myc antibody
conjugated to agarose. Normal mouse IgG was used as a control
for immunoprecipitation. Coprecipitated proteins were blotted
using antibodies against the indicated proteins. Five percent of the
total cell lysate was loaded as ‘‘input.’’ Representative results from
two independent experiments are shown.
(TIF)
Figure S5 RACK1 may be involved in the recruitment of
mature miRNAs to the RISC. Mature miRNA levels were
measured in RNA samples isolated from Ago2-containing
complexes from control Huh7 (NC) cells and RACK1-knockdown
(siRACK1) cells. miRNA levels were calculated as relative ratios.
Data represent the mean 6 SD of six independent experiments.
*p ,0.05.
(TIF)
Figure S6 KSRP is not required for RISC activity. A,
KSRP-knockdown Huh7 cells were established by shRNA-express-
ing lentiviral infection. B, Artificial synthetic miRNA oligonucleo-
tides function normally in KSRP-knockdown Huh7 cells. Control
and Ago2-knockdown cells were transfected with miR122 or
miR185 reporter plasmids with corresponding synthetic mature
miRNA oligonucleotides. Values were normalized to those obtained
from cells transfected with control synthetic oligonucleotides, which
were set to 1. Data represent the mean 6 SD of three independent
experiments. *, p,0.05.
(TIF)
Figure S7 KSRP does not bind with Ago2. Endogenous
KSRP was immunoprecipitated using anti-KSRP with Protein A/
G Sepharose. Normal rabbit IgG was used as a control for
immunoprecipitation. Co-precipitated proteins were blotted using
antibodies against Ago2.
(TIF)
Figure S8 The levels of KSRP expression are high in
liver tissues. A, Immunohistochemical analysis of KSRP protein
expression in hepatocellular carcinoma (HCC) and non-cancerous
surrounding tissues. Lower panels: magnified images of the
highlighted regions in the corresponding upper panels. Three
representative cases are shown. For a comparison, the sections used
here were almost the same parts used for determining RACK1
expression in Fig. 5. Scale bar, 500 mm. B, Relatively low
expression levels of KSRP both in colon carcinoma tissues (right
images) and non-cancerous surrounding tissues (left). Two repre-
sentative cases are shown. Again, for a comparison, the sections
used here were almost the same parts used for determining RACK1
expression in Fig. 5. Scale bar, 500 mm.
(TIF)
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